Market growth is largely driven by factors such as the technological advancements in lung cancer treatment, the increasing incidence and prevalence of lung cancer, the growing trend of smoking tobacco, the rising geriatric population, the increasing emphasis on early diagnosis and treatment of cancers, and the availability of reimbursement. However, the high cost of lung cancer diagnosis and surgery is expected to restrain the growth of this market during the forecast period.
read more..